The degradation and mineralisation of (400 mL, 3.15 mM) aqueous solutions of 2-hydroxypyridine (2-HPY), a primary intermediate formed during the photolytic degradation of 2-chloropyridine (2-CPY), 2-bromopyridine (2-BPY) and 2-iodopyridine (2-IPY), was studied at 50 degrees C, under 254 nm UV irradiation in a range of conditions. The rate of 2-HPY disappearance was found to heavily depend on agitation, dissolved oxygen, pH and hydroxyl radical scavenger presence. pH has a pronounced effect on the phototreatment of 2-HPY, i.e. 2-HPY removal is faster at lower pH, but except for their influence on the solution pH, Cl(-) or F(-) do not appear to affect 2-HPY rate of removal or mineralisation. 2-HPY removal rate increases with dissolved oxygen, thus indicating a prominent 2-HPY photooxidation pathway. Helium purging of the solution before and during the measurement reduced 2-HPY removal rate, thus supporting the existence of a photooxidation pathway. Pure photolytic 2-HPY removal, i.e. when photooxidation is limited, fits pseudo-first order kinetics, and a kinetic model was developed for 2-HPY formation and removal during 2-CPY, 2-BPY and 2-IPY photolytic degradation under laminar flow. The addition of radical scavenger (tert-butanol) had a detrimental effect on the photolytic degradation of 2-HPY. Complete total organic carbon removal was achieved.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chemosphere.2009.08.026 | DOI Listing |
Pharmaceuticals (Basel)
January 2025
Department of Pharmaceutical Analysis, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
Background/objectives: Janus kinase inhibitors open new horizons for small-molecule drugs in treating inflammatory bowel disease, with ritlecitinib demonstrating significant efficacy in clinical trials for ulcerative colitis and Crohn's disease. Ritlecitinib, a second-generation JAK3 inhibitor, is a novel therapeutic agent for alopecia areata and other autoimmune conditions.
Methods: A new stability-indicating UHPLC-DAD-MS/MS method was developed, validated, and applied for a forced degradation study of ritlecitinib under ICH guidelines.
Anal Methods
January 2025
Istanbul University, Faculty of Pharmacy, Department of Analytical Chemistry, 34116, Istanbul, Turkey.
In this study, a new reversed phase high performance liquid chromatography method using two detectors was developed for the analysis of degradation and process impurities of ivabradine in pharmaceutical preparations. A PDA detector set to 285 nm wavelength and a QDa detector set to positive scan mode were used in the method. In the developed method, the separation process was carried out in a Zorbax phenyl column with a gradient application of a 0.
View Article and Find Full Text PDFJ Pharm Biomed Anal
March 2025
Department of Pharmaceutical Analysis, School of Pharmacy, Guizhou Medical University, Gui'an New District, Guizhou 561113, PR China. Electronic address:
Dendrobine is a sesquiterpene alkaloid primarily used in the treatment of inflammatory diseases, immune system disorders, and conditions related to oxidative stress. To understand the possible degradation pathways of dendrobine for its quality control, we conducted an in-depth investigation of its degradation products using forced degradation methods. The separation of dendrobine and its degradation products was achieved on a Shim-pack XR-ODS III (75 mm × 2 mm, 1.
View Article and Find Full Text PDFInt J Mol Sci
December 2024
National Institutes for Food and Drug Control, Beijing 102629, China.
Ginsenoside Re was the major bioactive component found rich in C. A. Meyer, which exerted excellent cardiovascular protection, anti-inflammatory, and anti-oxidation effects.
View Article and Find Full Text PDFJ Sep Sci
January 2025
Department of Pharmacy, Pharmaceutical Sciences Postgraduate Research Program, Universidade Federal do Paraná, Curitiba, Paraná, Brazil.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!